Xiufeng Y. Pang

500 Dongchuan Road
Shanghai, 200241, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

Shenfu injection in sepsis-induced acute gastrointestinal injury: a narrative review of mechanisms and current evidence.

Shenfu injection in sepsis-induced acute gastrointestinal injury: a narrative review of mechanisms and current evidence.

Journal: Frontiers in pharmacology

Published: February 14, 2026

Pan-KRAS inhibition: unlocking broad-spectrum targeted therapy for KRAS-mutant cancers.

Pan-KRAS inhibition: unlocking broad-spectrum targeted therapy for KRAS-mutant cancers.

Journal: Cancer biology & medicine

Published: February 10, 2026

Elevated Level of miR-711 Is Associated With Inflammation and Disease Progression in Patients With Severe Acute Pancreatitis.

Elevated Level of miR-711 Is Associated With Inflammation and Disease Progression in Patients With Severe Acute Pancreatitis.

Journal: Microbiology and immunology

Published: September 23, 2025

Study of association of sedentary time and physical activity with development of chronic obstructive pulmonary disease in non-smoking women aged 40 years and above in Songjiang District, Shanghai

Study of association of sedentary time and physical activity with development of chronic obstructive pulmonary disease in non-smoking women aged 40 years and above in Songjiang District, Shanghai

Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

Published: September 18, 2025

Cyclic di-GMP suppresses cancer metastasis by targeting proteasome 26S subunit non-ATPase 3 independently of STING.

Cyclic di-GMP suppresses cancer metastasis by targeting proteasome 26S subunit non-ATPase 3 independently of STING.

Journal: Signal transduction and targeted therapy

Published: June 24, 2025

Spleen-targeted NeoPol-mL242 mRNA vaccine induces robust T-cell responses in a hepatocellular carcinoma model.

Spleen-targeted NeoPol-mL242 mRNA vaccine induces robust T-cell responses in a hepatocellular carcinoma model.

Journal: Journal of nanobiotechnology

Published: June 14, 2025

Mycosubtilin Induces G1 Phase Block and Autophagy in Cervical Cancer HeLa Cells.

Mycosubtilin Induces G1 Phase Block and Autophagy in Cervical Cancer HeLa Cells.

Journal: Probiotics and antimicrobial proteins

Published: March 31, 2025

Benzyl isothiocyanate triggers apoptosis by initiating autophagy through the generation of ROS and modulating the MAPK and PI3K-AKT pathway in cervical cancer cells.

Benzyl isothiocyanate triggers apoptosis by initiating autophagy through the generation of ROS and modulating the MAPK and PI3K-AKT pathway in cervical cancer cells.

Journal: International immunopharmacology

Published: March 26, 2025

Study on the association of diet pattern with chronic obstructive pulmonary disease in population aged 40 years and above in Songjiang District, Shanghai

Study on the association of diet pattern with chronic obstructive pulmonary disease in population aged 40 years and above in Songjiang District, Shanghai

Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

Published: December 16, 2024

A pan-KRAS inhibitor and its derived degrader elicit multifaceted anti-tumor efficacy in KRAS-driven cancers.

A pan-KRAS inhibitor and its derived degrader elicit multifaceted anti-tumor efficacy in KRAS-driven cancers.

Journal: Cancer cell

Published: October 05, 2024

Design, Synthesis, and Pharmacological Evaluation of Multisubstituted Pyrido[4,3-d]pyrimidine Analogues Bearing Deuterated Methylene Linkers as Potent KRASG12D Inhibitors.

Design, Synthesis, and Pharmacological Evaluation of Multisubstituted Pyrido[4,3-d]pyrimidine Analogues Bearing Deuterated Methylene Linkers as Potent KRASG12D Inhibitors.

Journal: Journal of medicinal chemistry

Published: November 03, 2023

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance.

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance.

Journal: Journal of medicinal chemistry

Published: May 02, 2023

Showing 1-12 of 58

Last Updated: 09/26/2026